Advances in Combined Modality Treatments for Prostate Cancer

2,099
Total downloads
14k
Total views and downloads

Participate in this topic

Articles

CASE REPORT

Published on 01 Dec 2025

Case Report: High-volume, aggressive prostate cancer with borderline psa levels diagnosed by PSMA PET/CT–based comprehensive radiographic scheme and cognitive fusion targeted biopsy

Yiheng Zhou
Renyuan Qiu
Mengmeng Dou
Wenkai Bi
Yong Yu

doi 10.3389/fonc.2025.1721477

549 views

ORIGINAL RESEARCH

Published on 01 Oct 2025

Real-world multicenter study of rezvilutamide plus androgen deprivation therapy in Chinese patients with high-volume metastatic hormone-sensitive prostate cancer

Shuang Peng
Ruochen Zhang
Zijun Zou
Qichen Wei
Caixia Dai
Jinfeng Wu
Liefu Ye
Yongbao Wei
Li Huang

doi 10.3389/fonc.2025.1657772

946 views

ORIGINAL RESEARCH

Published on 26 Sep 2025

Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimen

Daniel Sentana-Lledo
Arjun Gupta
Carmine Rossi
Sabree Burbage
Jill Korsiak
Lilian Diaz
Gordon Wong
Dominic Pilon
Ibrahim Khilfeh
Alicia K. Morgans

doi 10.3389/fonc.2025.1650378

1,275 views

CASE REPORT

Published on 27 Aug 2025

Case Report: Primary extraskeletal osteosarcoma in prostate

Youli Xu
Xing Chen

doi 10.3389/fonc.2025.1558053

869 views

REVIEW

Published on 25 Jul 2025

Triplet systemic therapy for hormone-sensitive prostate cancer: a critical review with a multidisciplinary approach

Almudena Zapatero
Teresa Alonso-Gordoa
Alfredo Rodríguez Antolín
Felipe Couñago
Noelia Sanmamed
Mario Domínguez Esteban
Marta López Valcárcel
Ray Manneh
Ángel Borque-Fernando
1 more
Pablo Maroto

doi 10.3389/or.2025.1599292

3,811 views

CASE REPORT

Published on 23 Jul 2025

Prostate cancer inducing secondary linitis plastica of the rectum: a rare case report and literature review

Dongpo Zhang
Jun Li
Tao Sun
Ling Zhang
Lian Wang
Quan Gan
Xiaoxiao Xing
Yong Zhang
Yue Wang
1 more
Junyi Li

doi 10.3389/fonc.2025.1597367

1,189 views

REVIEW

Published on 18 Jun 2025

Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors

Hua Lu
Zhaojun Teng
Jiajia Wang
Wenchao Zhang

doi 10.3389/fimmu.2025.1583363

3,118 views
1 citation

Share on

Frontiers in Surgery

Surgical Oncology

Other participating journals

Frontiers in Oncology
- Surgical Oncology
- 3.3 impact factor
- 6.9 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

14kTopic views
11kArticle views
2,099Article downloads

View impact

Articles

Case Report: High-volume, aggressive prostate cancer with borderline psa levels diagnosed by PSMA PET/CT–based comprehensive radiographic scheme and cognitive fusion targeted biopsy

Real-world multicenter study of rezvilutamide plus androgen deprivation therapy in Chinese patients with high-volume metastatic hormone-sensitive prostate cancer

Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimen

Case Report: Primary extraskeletal osteosarcoma in prostate

Triplet systemic therapy for hormone-sensitive prostate cancer: a critical review with a multidisciplinary approach

Prostate cancer inducing secondary linitis plastica of the rectum: a rare case report and literature review

Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors

Frontiers in Surgery

Surgical Oncology

Other participating journals

Frontiers in Oncology

Surgical Oncology